Immunic (IMUX) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immunic (IMUX) has outperformed Stablecoin Development (SDEV) over the past year, losing 13.3% versus a loss of 66.8%. Over five years, IMUX leads with a -91.2% price change compared with -99.9% for SDEV. Immunic is the larger company by market cap ($103.2 million vs $103.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMUX | SDEV |
|---|---|---|
| Share price | $7.56 | $1.99 |
| Market cap | $103.15M | $102.99M |
| 1-day change | -0.92% | -28.42% |
| YTD return | +42.88% | -92.94% |
| 1-year return | -13.30% | -66.83% |
| 5-year return | -91.20% | -99.94% |
| EPS (TTM) | $-3.83 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.43 | $99.75 |
| 52-week low | $5.06 | $0.78 |
| Distance from 52-week high | -56.63% | -98.01% |
| Average volume | 277.39K | 11.42M |
| Shares outstanding | 13.64M | 51.75M |
| Employees | — | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMUX has outperformed SDEV by 53.5 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
IMUX vs SDEV FAQ
Which is bigger, Immunic or Stablecoin Development?
Immunic (IMUX) is larger, with a market capitalization of $103.15M compared with $102.99M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, IMUX or SDEV?
IMUX returned -13.30% over the past 12 months, compared with -66.83% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Immunic and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.